ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,419, issued on Dec. 23, was assigned to Bactoclear Holdings PTE. LTD. (Singapore).

"Chimeric proteins for selective lysis of bacteria" was invented by Anisha Ambady (Bangalore, India), Vivek Daniel Paul (Bangalore, India) and R. Sanjeev Saravanan (Bengaluru, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides chimeric ectolysins useful for selective suppression of certain targeted bacterial species while having little to no effect on closely related non-targeted bacterial species. Specifically, the disclosure provides polypeptides for selective suppression of growth of Staphylococcus aureus and/or S. hominis but not S...